Voloridge Investment Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-137,974
Closed -$1.08M 1236
2024
Q2
$1.08M Buy
137,974
+109,979
+393% +$815K ﹤0.01% 1040
2024
Q1
$199K Buy
+27,995
New +$185K ﹤0.01% 1112
2023
Q3
Sell
-290,394
Closed -$1.6M 1466
2023
Q2
$1.6M Sell
290,394
-351,984
-55% -$1.89M 0.01% 1030
2023
Q1
$4.01M Buy
642,378
+4,511
+0.7% +$25.1K 0.02% 750
2022
Q4
$2.97M Sell
637,867
-587,319
-48% -$2.89M 0.02% 854
2022
Q3
$5.72M Buy
1,225,186
+806,904
+193% +$5.09M 0.03% 609
2022
Q2
$2.48M Buy
+418,282
New +$4.66M 0.01% 950
2022
Q1
Sell
-20,007
Closed -$654K 1488
2021
Q4
$654K Sell
20,007
-26,492
-57% -$1.07M ﹤0.01% 1363
2021
Q3
$1.91M Sell
46,499
-29,501
-39% -$1.07M 0.01% 1070
2021
Q2
$2.74M Buy
+76,000
New +$2.8M 0.02% 869
2020
Q4
Sell
-15,000
Closed -$834K 1406
2020
Q3
$834K Buy
+15,000
New +$794K 0.01% 988

Other funds holding GDRX

Voloridge Investment Management's GDRX Position: Q3 2024 in Review

Voloridge Investment Management sold out of GoodRx Holdings (GDRX) in Q3 2024, closing a stake of 137,974 shares — an estimated $1.08M sold.

Voloridge Investment Management first reported a position in GDRX in Q3 2020 and held it in 11 quarters. The position peaked at $5.72M in Q3 2022. 168 funds tracked by Wall St. Rank hold GDRX as of Q3 2024.

  • Voloridge Investment Management reported no remaining GoodRx Holdings position as of Q3 2024 after selling out during the quarter.
  • Voloridge Investment Management sold 137,974 GoodRx Holdings shares in Q3 2024, an estimated $1.08M.
  • Voloridge Investment Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 11 quarters.
  • Voloridge Investment Management's GoodRx Holdings position peaked at $5.72M in Q3 2022.
  • 168 funds tracked by Wall St. Rank held GoodRx Holdings as of Q3 2024.

Based on Voloridge Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.